ACTIVITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN A POPULATION OF NORTHERN SWEDEN

被引：12
|
作者：
RANBY, M
SUNDELL, IB
JOHNSON, O
LEDIN, MC
DAHLEN, G
机构：
[1] UMEA UNIV,DEPT PATHOL,S-90187 UMEA,SWEDEN
[2] UMEA UNIV,DEPT MED,S-90187 UMEA,SWEDEN
[3] UMEA UNIV,DEPT CLIN CHEM,S-90187 UMEA,SWEDEN
[4] NATL INST OCCUPAT HLTH,UMEA,SWEDEN
来源：
FIBRINOLYSIS | 1990年 / 4卷
关键词：
Age; PAI-1; activity; Population study; Sex;
D O I：
10.1016/0268-9499(90)90358-Q
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Plasma PAI-1 activities in an adult population living in the county of Umeå, Sweden was studied by analysis of 367 randomly selected people. Men and women in the age range 20-49 years had different distributions of PAI-1 activity, whereas no sex difference was evident in the age range 50 to 59. The following reference limits, defined as containing 95% of the individuals, were determined: men 20-49 years; 0.4 to 23.3 U/ml, women 20-49 years; 0.2 to 18.0 U/ml and all individuals above 50 years; 0.5 to 40.3 U/ml. The upper reference limits can be used to define individuals with elevated levels of PAI-1 activity. © 1990.
引用
收藏
页码：54 / 55
页数：2
相关论文
共 50 条
  • [1] STABILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)
    LINDAHL, TL
    SIGURDARDOTTIR, O
    WIMAN, B
    [J]. THROMBOSIS AND HAEMOSTASIS, 1989, 62 (02) : 748 - 751
  • [2] THE ACTIVITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) OF HUMAN PLATELET
    BOOTH, NA
    CROLL, A
    BENNETT, B
    [J]. FIBRINOLYSIS, 1990, 4 : 138 - 140
  • [3] Plasminogen-activator inhibitor-1 in (PAI-1) gastric cancer
    Tabuchi, Y
    Nakamura, T
    Miyamura, K
    Nakae, S
    [J]. PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 447 - 450
  • [4] ROLE OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN DIC
    MATSUDA, T
    ASAKURA, H
    SAITO, M
    JOKAJI, H
    UOTANI, C
    KUMABASHIRI, I
    MORISHITA, E
    YAMAZAKI, M
    [J]. THROMBOSIS RESEARCH, 1991, 63 (02) : 269 - 269
  • [5] PLASMINOGEN-ACTIVATOR INHIBITOR-1(PAI-1) AND TISSUE-PLASMINOGEN ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR-1(TPA-PAI-1) IN IDDM - PROFILE BY COMPLICATIONS
    SUMINSKI, R
    DASILVA, S
    SMITH, M
    ERBEY, J
    [J]. DIABETES, 1994, 43 : A197 - A197
  • [6] REACTIVATION OF LATENT PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) INVIVO
    VAUGHAN, DE
    DECLERCK, PJ
    VANHOUTTE, E
    DEMOL, M
    COLLEN, D
    [J]. CIRCULATION, 1990, 82 (04) : 601 - 601
  • [7] REACTIVATION OF LATENT PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) INVIVO
    VAUGHAN, DE
    DECLERCK, PJ
    VANHOUTTE, E
    DEMOL, M
    COLLEN, D
    [J]. ARTERIOSCLEROSIS, 1990, 10 (05): : A909 - A909
  • [8] DAYTIME FLUCTUATIONS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN POPULATIONS WITH HIGH PAI-1 LEVELS
    JUHANVAGUE, I
    ALESSI, MC
    RACCAH, D
    AILLAUD, MF
    BILLEREY, M
    ANSALDI, J
    PHILIPJOET, C
    VAGUE, P
    [J]. THROMBOSIS AND HAEMOSTASIS, 1992, 67 (01) : 76 - 82
  • [9] Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population
    White, Marquitta J.
    Kodaman, Nuri M.
    Harder, Reed H.
    Asselbergs, Folkert W.
    Vaughan, Douglas E.
    Brown, Nancy J.
    Moore, Jason H.
    Williams, Scott M.
    [J]. PLOS ONE, 2015, 10 (08):
  • [10] THE CHARACTERIZATION OF A NOVEL INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN-VITRO
    FAINT, RW
    CHARLTON, P
    BENT, F
    BRYANS, J
    MACKIE, I
    BEVAN, P
    [J]. BLOOD, 1994, 84 (10) : A73 - A73
12345